Overview of Latest AHA Guidelines on the Management of Dyslipidemia Key Changes and Differences From Previous Guidelines Prior Cholesterol Guideline 2013 Cholesterol Guidelines Where Are We Now ID: 910673
Download Presentation The PPT/PDF document "2018 Cholesterol Guidelines" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
2018 Cholesterol Guidelines
Slide2Slide3Overview of Latest AHA Guidelines
on the Management
of Dyslipidemia:
Key Changes and Differences From
Previous Guidelines
Slide4Prior Cholesterol Guideline
2013
Slide5Cholesterol Guidelines
Where Are We Now?
Slide6Implications of the Latest Guidelines for Clinical Care
Slide7Implications of Primary Prevention Recommendations
Slide8Primary Prevention
2018 Cholesterol Guidelines
Slide9ASCVD Risk Enhancers
2018 Cholesterol Guidelines
Slide10Coronary Artery Calcium
Slide11Primary Prevention
Statin Initiation Parameters
Slide12Defining Very High-Risk ASCVD
Slide13Secondary Prevention
2018 Cholesterol Guidelines
Slide14Value Assessment
Slide15The 2018 Cholesterol Guidelines
What Do the Recommendations Mean for Non-Statin Therapies?
Slide16Systematic Review of Controlled Trials
Slide17IMPROVE-IT, FOURIER, AND ODYSSEY OUTCOMES
Included in Systematic Review
Slide18Systematic Review: IMPROVE-IT[a,b]
Slide19Systematic Review: FOURIER[a,b]
Slide20Systematic Review: ODYSSEY OUTCOMES[a,b]
Slide21Continual Reassessment Crucial
Slide22Recommendations for Adding Ezetimibe and/or PCSK9 Inhibitor
Slide23Implementing the Latest Guidelines Into Patient Care
Slide24Cardiovascular Team-Based Care
Role of Advanced Practice Providers
Slide25Implementation Recommendations
Slide26Strategies to Improve Guideline Implementation
Slide27Checklist for Clinician-Patient Shared Decision Making for Initiating Therapy
Slide28Statin-Associated Side Effects
Statin-Associated Muscle Symptoms (SAMS)
Slide29Summary of Top 10 Takeaways
Slide30Summary of Top 10 Takeaways (cont)
Slide31Summary of Top 10 Takeaways (cont)
Slide32National Lipid Association: Tear Sheet
2018 Cholesterol Guideline at www.lipid.org
Slide33Abbreviations
Slide34Abbreviations (cont)